Stock Research for PFE

Featured Broker: Ally Invest

Get the due diligence for another stock.


PFE Stock Chart & Research Data

The PFE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PFE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PFE Due diligence Resources & Stock Charts

The PFE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PFE Detailed Price Forecast - CNN Money CNN View PFE Detailed Summary - Google Finance
Yahoo View PFE Detailed Summary - Yahoo! Finance Zacks View PFE Stock Research & Analysis -

Stock Analysis

TradeIdeas View PFE Trends & Analysis - Trade-Ideas Barrons View PFE Major Holders - Barrons
NASDAQ View PFE Call Transcripts - NASDAQ Seeking View PFE Breaking News & Analysis - Seeking Alpha
Spotlight View PFE Annual Report - OTC Report View PFE OTC Short Report -
TradeKing View PFE Fundamentals - TradeKing Charts View PFE SEC Filings - Bar Chart
WSJ View Historical Prices for PFE - The WSJ Morningstar View Performance/Total Return for PFE - Morningstar
MarketWatch View the Analyst Estimates for PFE - MarketWatch CNBC View the Earnings History for PFE - CNBC
StockMarketWatch View the PFE Earnings - StockMarketWatch MacroAxis View PFE Buy or Sell Recommendations - MacroAxis
Bullish View the PFE Bullish Patterns - American Bulls Short Pains View PFE Short Pain Metrics -

Social Media Mentions

StockTwits View PFE Stock Mentions - StockTwits PennyStocks View PFE Stock Mentions - PennyStockTweets
Twitter View PFE Stock Mentions - Twitter Invest Hub View PFE Investment Forum News - Investor Hub
Yahoo View PFE Stock Mentions - Yahoo! Message Board Seeking Alpha View PFE Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PFE - Insider Cow View Insider Transactions for PFE - Insider Cow
CNBC View PFE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PFE - OTC Markets
Yahoo View Insider Transactions for PFE - Yahoo! Finance NASDAQ View Institutional Holdings for PFE - NASDAQ

Stock Charts

FinViz View PFE Stock Insight & Charts - StockCharts View PFE Investment Charts -
BarChart View PFE Stock Overview & Charts - BarChart Trading View View PFE User Generated Charts - Trading View

Latest Financial News for PFE

4 Conservative Dividend Stocks That Belong in Every Income Investors Portfolio
Posted on Saturday July 21, 2018

All four of these names have very strong cash flows that allow them to not only pay better than 3% dividends, but also to buy back stock. Two are consumer staples, a sector that's been the S&P 500's second-best performer over the past month (up 3.83%). The others are in health care, which has been the S&P 500's No. 3 best sector (+3%) during the past month.

Pharmaceutical Companies Seek Stability in Trump Drug Cost Fight
Posted on Friday July 20, 2018

Several major pharmaceutical companies lowered their spending on lobbyists in the second quarter of 2018, a time of uncertainty as President Donald Trump’s administration continued its campaign to lower drug costs for consumers. Pharmaceutical Research and Manufacturers of America spent $5.54 million between April and June, down 7.7 percent from the same period last year, according to disclosures released by the federal government on Friday. Companies including Johnson & Johnson and Bayer Corp. decreased their spending from the first quarter, when several companies set lobbying records amid the first signs of Trump’s moves to reduce out-of-pocket medicine costs.

Pfizer gets FDA approval for drug similar to Amgen's Neupogen
Posted on Friday July 20, 2018

Pfizer Inc. (pfe) said late Friday it received Food and Drug Administration approval to sell a biotech drug that is similar to Amgen Inc.'s (amgn) Neupogen. Pfizer's product is named Nivestym, which is intended to reduce the likelihood of infections in cancer patients receiving chemotherapy. In a statement, Pfizer said it expects to sell Nivestym at "a significant discount to the current wholesale acquisition cost" of Neupogen.

Johnson & Johnson’s Revenues Came in ahead of Estimates in Q2
Posted on Friday July 20, 2018

Johnson & Johnson (JNJ) announced its Q2 2018 earnings results on July 17. JNJ stock rose ~3.5% on the day and ended at a closing price of $129.12. On July 16, the stock closed at $124.69.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.